Related Articles
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment
Effects of 1α,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factors
FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway
Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line